e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Asthma and lung immunology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
Yavuz Havlucu (Manisa, Turkey), Yavuz Havlucu, Arzu Yorgancioglu, Fikret Kurhan, Tugba Goktalay, Aysin Sakar Coskun, Pinar Celik
Source:
International Congress 2015 – Asthma and lung immunology
Session:
Asthma and lung immunology
Session type:
Thematic Poster Session
Number:
1091
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yavuz Havlucu (Manisa, Turkey), Yavuz Havlucu, Arzu Yorgancioglu, Fikret Kurhan, Tugba Goktalay, Aysin Sakar Coskun, Pinar Celik. Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients. Eur Respir J 2015; 46: Suppl. 59, 1091
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013
Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Real life experience of omalizumab on selected children with severe allergic asthma
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Asthma control and exacerbation rate with omalizumab in Italian patients with severe allergic asthma: PROXIMA study
Source: International Congress 2017 – Asthma management
Year: 2017
Asthma among allergic rhinitis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 108s
Year: 2003
Polysensitization and comorbidities of asthma and rhinitis in adults in the EGEA study
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015
The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Source: International Congress 2016 – Asthma management
Year: 2016
Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
The impact of psychological distress on allergic rhinitis and asthma control
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
A phenotype of onset of adult asthma with co-morbid rhinitis
Source: Annual Congress 2013 –Asthma
Year: 2013
APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
25(OH) vitamin D levels in pediatric asthma and allergic rhinitis
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Allergic rhinitis does it have an impact on controller asthma therapy choice
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Asthma control, symptoms and exacerbations across treatment levels in patients with asthma
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept